AAPL 170.33 +0.29 (+0.17%)MSFT 108.2 +0.55 (+0.51%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 170.33 +0.29 (+0.17%)MSFT 108.2 +0.55 (+0.51%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Company Profile ABLX Quote Ablynx NV

Ablynx NV Quote

Ablynx NV (ABLX)

52.78 -0.02 Healthcare

CEO

Edwin Moses

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Ablynx NV is a clinical-stage biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.